- About UCB US
- R & D
- Contact Us
Everything we do starts with one simple question: "How can we create more value for people living with severe diseases?"
Just because our medicines treat thousands of people around the world doesn't mean our job is done.
For us, it's vital that we listen to the constantly evolving needs of patients and their families.
Working with physicians and healthcare professionals, we are engaging more with patients to better understand their clinical, economic, social and personal needs. What matters most is how they feel in their everyday life as they progress on their healthcare journey. Because we're not just treating a disease. We're caring for individual people.
Patients inspire us to bring them value through more cutting-edge science, more innovative drugs, and more practical solutions - so that they, and their carers, can get on with their lives.
There is no such thing as an "average patient." We don't want to do science for science's sake, but are seeking to embed the real needs of specific patient populations in our science and innovation process.
To achieve this, we are leveraging scientific advances and skills in areas such as genetics, biomarkers and human biology. We want to enhance our knowledge of the various expressions of a disease and the real life experience of patients so that, ultimately, our teams are able to deliver the right drug and the right care to the right patient.
Sheila, living with Parkinson's disease